The LDN Shop
Visit our e-commerce website for Conferences, Webinars, Medical Membership, eBooks etc
Ulrich Lanius, PhD and Galyn Forster, MS, LPC - Opioid Antagonists and Traumatic Brain Injury (2017 Conference) (LDN, low dose naltrexone)
They begin their presentation by discussing Naltrexone and seizure activity, as demonstrated through clinical trials. They found that later dosage adjustments were helpful in reducing the cognitive effects.
Jill Brook M.A. - Dietary Strategies to Fight Autoimmunity (2017 Conference) (LDN, low dose naltrexone)
Jill Brook, MA shares her presentation on Nutrition at the LDN 2017 Conference.
Jarred Younger, PhD - Calming microglia: a future method for treating multiple sclerosis (2016 Conference) (LDN, low dose naltrexone)
Dana Flavin, MD - Reversing Cancer with Biochemistry (2018 Conference) (LDN, low dose naltrexone)
Dr Dana Flavin shares her presentation on Reversing Cancer at the LDN 2018 Conference.
Mark Shukhman, MD - Sexual Function (2016 Conference) (LDN, low dose naltrexone)
Kent Holtorf, MD - Thyroid Disorders (2016 Conference) (LDN, low dose naltrexone)
Jill Cottel, MD - Treating the Zebras in Primary Care (2017 Conference) (LDN, low dose naltrexone)
In this presentation Dr Cottel shares case studies of patients:
36 year old woman with Ehlers-Danlos Syndrome. This lady was started on Low Dose Naltrexone (LDN) at 1.5mg, increased to 3 mg and found she lost her earlier improvement but on going down to a much lower dose she improved significantly.